Coronary Artery Disease: References

Content provided by Healthwise

References

Citations

1. Williams CL, et al. (2002). Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 106(1): 143–160.

2. McSweeney JC, et al. (2003). Women's early warning symptoms of acute myocardial infarction. Circulation, 108(21): 2619–2623.

3. American Heart Association (2006). Heart disease and stroke statistics—2006 update. Circulation, 113(6): e85–e151.

4. Grundy SM (2001). United States cholesterol guidelines 2001: Expanded scope of intensive low-density lipoprotein-lowering therapy. American Journal of Cardiology, 88(7B): 23J–27J.

5. U.S. Preventive Services Task Force (2008). Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 148(11): 846–854.

6. Koenig W (2001). Inflammation and coronary artery disease: An overview. Cardiology in Review, 9(1): 31–35.

7. Snow V, et al. (2004). Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 141(7): 562–567. Also available online: http://www.annals.org/cgi/reprint/141/7/562.pdf.

8. Goldenberg I, et al. (2003). Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease. Archives of Internal Medicine, 163(19): 2301–2305.

9. Silagy C, et al. (2006). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

10. Jolliffe JA, et al. (2006). Exercise-based rehabilitation for coronary heart disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

11. Hayden M, et al. (2002). Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 136(2): 161–172.

12. Foster C, et al. (2004). Cardiovascular disorders: Primary prevention. Clinical Evidence (12): 159–192.

13. Smith SC Jr, et al. (2006). ACC/AHA/SCAI 2005 guidelines update for percutaneous coronary intervention: Summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation, 113(1): 156–175.

14. Gami A (2006). Secondary prevention of ischaemic cardiac events, search date July 2004. Online version of Clinical Evidence (15): 1–31.

15. Morice M (2002). A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New England Journal of Medicine, 346(23): 1773–1780.

Other Works Consulted

• Hirsch J, et al. (2008). Executive summary: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest, 133(6): 71–109.

• U.S. Preventive Services Task Force (2008). Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 148(11): 846–854.

Last updated:	May 29, 2008
Author:	Robin Parks, MS
Reviewed By:	Caroline S. Rhoads, MD - Internal Medicine, Ruth Schneider, MPH, RD - Diet and Nutrition
Editors:	Kathleen M. Ariss, MS, Pat Truman, MATC